iShares Biotechnology ETF (IBB) |
| 172.19 2.82 (1.66%) 04-13 16:00 |
| Open: | 170.38 |
| High: | 173.355 |
| Low: | 170.175 |
| Volume: | 1,407,700 |
| Market Cap: | 8,299(M) |
| PE Ratio: | 23.55 |
| Exchange: | NASDAQ Global Market |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 203.15 |
| Resistance 1: | 173.93 |
| Pivot price: | 167.26 |
| Support 1: | 165.12 |
| Support 2: | 159.68 |
| 52w High: | 179.64 |
| 52w Low: | 116.25 |
The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Sat, 11 Apr 2026
Best Biotech ETFs for 2026 and How to Invest in Them - The Motley Fool
Tue, 07 Apr 2026
XBI vs. IBB: The Biotech ETF Showdown That Analysts Say Has a Clear Winner in 2026 - 24/7 Wall St.
Thu, 02 Apr 2026
Biotech Is Holding Steady In 2026 (NASDAQ:IBB) - Seeking Alpha
Tue, 31 Mar 2026
Biotech Stocks Are Up About 35% in the Past Year and Analysts Say the Biggest Gains Are Still Ahead - 24/7 Wall St.
Sat, 21 Mar 2026
DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing - Yahoo Finance
Wed, 25 Feb 2026
How to Invest in iShares Biotechnology ETF (IBB) - The Motley Fool
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
